Hearing Loss Risk Added to Impotence Drug Labeling

Labeling on erectile dysfunction (ED) drugs Viagra, Cialis, and Levitra will more prominently display information on the potential risk of sudden hearing loss, and guide consumers on what to do if they experience sudden problems with their hearing, according to an announcement from the U.S. Food and Drug Administration. The labeling changes are a result of a number of cases in which patients taking these drugs reported sudden hearing loss, sometimes with dizzinesss and/or ringing in the ears. The FDA is advising patients who are taking Cialis, Levitra, or Viagra and experience sudden hearing loss to immediately stop taking the drug and seek prompt medical attention.

• FDA Announcement on Labeling Changes for ED Drugs
• Reuters: FDA Adds Hearing Loss Risk to Viagra, Others
• More Information on ED Drugs: Viagra | Cialis | Levitra